Skip to main content
Premium Trial:

Request an Annual Quote

Incyte, Zeneca Announce Agrigenomics Partnership

Premium

WILMINGTON, Del.--Incyte Pharmaceuticals and Zeneca announced last week a collaboration in agricultural genomics that will extend the existing pharmaceutical collaboration between the two companies initiated in 1996 with agreements covering access to several Incyte database products.

Under the multiyear collaboration, Zeneca will have access to Incyte's PhytoSeq database. Incyte will apply its high-throughput gene sequencing and bioinformatics capabilities toward the generation of gene sequence and expression information for crop plants designated by Zeneca to be included in PhytoSeq which will contain sequence information from a range of agriculturally important crops, including wheat, maize, and rice.

In addition, Zeneca will have access to Incyte's microarray technology for the study of gene pathways and to monitor gene expression in plants. Incyte will provide Zeneca with data from both custom and pre-fabricated microarrays. The companies said this will provide an unprecedented level of information, allowing researchers at Zeneca to study multigenic pathways, or thousands of genes at a time, in a single experiment.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.